Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Johnson & Johnson confirms FDA approval of booster dose for COVID-19 vaccine » 18:47
10/20/21
10/20
18:47
10/20/21
18:47
JNJ

Johnson & Johnson

$163.76 /

-0.095 (-0.06%)

Johnson & Johnson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$163.76 /

-0.095 (-0.06%)

JNJ Johnson & Johnson
$163.76 /

-0.095 (-0.06%)

07:48 Today Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
06:35 Today Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
JNJ Johnson & Johnson
$163.76 /

-0.095 (-0.06%)

JNJ Johnson & Johnson
$163.76 /

-0.095 (-0.06%)

JNJ Johnson & Johnson
$163.76 /

-0.095 (-0.06%)

JNJ Johnson & Johnson
$163.76 /

-0.095 (-0.06%)

Hot Stocks
Johnson & Johnson, Moderna COVID-19 vaccine boosters get FDA authorization » 16:52
10/20/21
10/20
16:52
10/20/21
16:52
JNJ

Johnson & Johnson

$163.76 /

-0.095 (-0.06%)

, MRNA

Moderna

$333.00 /

-0.53 (-0.16%)

, PFE

Pfizer

$42.79 /

+0.7 (+1.66%)

, BNTX

BioNTech

$269.68 /

+6.7 (+2.55%)

The U.S. FDA took action…

The U.S. FDA took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations. The agency is amending the emergency use authorizations for COVID-19 vaccines to allow for the use of a single booster dose. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$42.79 /

+0.7 (+1.66%)

MRNA Moderna
$333.00 /

-0.53 (-0.16%)

JNJ Johnson & Johnson
$163.76 /

-0.095 (-0.06%)

BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

JNJ Johnson & Johnson
$163.76 /

-0.095 (-0.06%)

07:48 Today Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
06:35 Today Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
MRNA Moderna
$333.00 /

-0.53 (-0.16%)

10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Piper Sandler
Moderna upgraded to Overweight from Neutral at Piper Sandler
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
PFE Pfizer
$42.79 /

+0.7 (+1.66%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
PFE Pfizer
$42.79 /

+0.7 (+1.66%)

MRNA Moderna
$333.00 /

-0.53 (-0.16%)

JNJ Johnson & Johnson
$163.76 /

-0.095 (-0.06%)

BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

MRNA Moderna
$333.00 /

-0.53 (-0.16%)

JNJ Johnson & Johnson
$163.76 /

-0.095 (-0.06%)

BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

MRNA Moderna
$333.00 /

-0.53 (-0.16%)

JNJ Johnson & Johnson
$163.76 /

-0.095 (-0.06%)

BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

MRNA Moderna
$333.00 /

-0.53 (-0.16%)

JNJ Johnson & Johnson
$163.76 /

-0.095 (-0.06%)

Conference/Events
Ideaya Biosciences management to meet virtually with Northland » 16:26
10/20/21
10/20
16:26
10/20/21
16:26
IDYA

Ideaya Biosciences

$22.52 /

-0.5 (-2.17%)

Virtual Meeting to be…

Virtual Meeting to be held on October 26 hosted by Northland.

ShowHide Related Items >><<
IDYA Ideaya Biosciences
$22.52 /

-0.5 (-2.17%)

IDYA Ideaya Biosciences
$22.52 /

-0.5 (-2.17%)

09/22/21 Stifel
Ideaya Biosciences initiated with a Hold at Stifel
06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
IDYA Ideaya Biosciences
$22.52 /

-0.5 (-2.17%)

  • 08
    Jul
IDYA Ideaya Biosciences
$22.52 /

-0.5 (-2.17%)

On The Fly
Wall Street in Fives - Must Read Lists for Wednesday » 16:26
10/20/21
10/20
16:26
10/20/21
16:26
NFLX

Netflix

$625.15 /

-13.96 (-2.18%)

, NVAX

Novavax

$136.84 /

-23.6 (-14.71%)

, VZ

Verizon

$53.61 /

+1.25 (+2.39%)

, MU

Micron

$68.27 /

+0.69 (+1.02%)

, UAL

United Airlines

$45.94 /

-0.28 (-0.61%)

, F

Ford

$16.05 /

+0.625 (+4.05%)

, QRVO

Qorvo

$169.45 /

+0.87 (+0.52%)

, WDC

Western Digital

$56.41 /

+0.77 (+1.38%)

, FSLR

First Solar

$103.24 /

-4.97 (-4.59%)

, SYF

Synchrony

$51.95 /

-0.41 (-0.78%)

, PYPL

PayPal

$258.00 /

-13.63 (-5.02%)

, PINS

Pinterest

$62.68 /

+7.085 (+12.74%)

, FB

Facebook

$340.85 /

+0.8 (+0.24%)

, XOM

Exxon Mobil

$63.86 /

+0.36 (+0.57%)

, DD

DuPont

$73.24 /

+0.99 (+1.37%)

, CC

Chemours

$30.62 /

+0.11 (+0.36%)

, NXTP

NextPlay Technologies

$2.46 /

-0.075 (-2.96%)

, RDUS

Radius Health

$18.02 /

+2.555 (+16.52%)

, RAD

Rite Aid

$14.22 /

+0.59 (+4.33%)

, CNI

Canadian National

$130.51 /

+6.16 (+4.95%)

, ATIP

ATI Physical Therapy

$2.86 /

-0.79 (-21.64%)

, HCSG

Healthcare Services

$20.01 /

-3.26 (-14.01%)

, BIIB

Biogen

$266.28 /

-1.53 (-0.57%)

, EAT

Brinker

$44.24 /

-4.68 (-9.57%)

, ABT

Abbott

$123.32 /

+3.94 (+3.30%)

, CP

Canadian Pacific

$74.70 /

+1.205 (+1.64%)

, ANTM

Anthem

$423.88 /

+30.33 (+7.71%)

Get caught up quickly on…

ShowHide Related Items >><<
XOM Exxon Mobil
$63.86 /

+0.36 (+0.57%)

WDC Western Digital
$56.41 /

+0.77 (+1.38%)

VZ Verizon
$53.61 /

+1.25 (+2.39%)

UAL United Airlines
$45.94 /

-0.28 (-0.61%)

SYF Synchrony
$51.95 /

-0.41 (-0.78%)

RDUS Radius Health
$18.02 /

+2.555 (+16.52%)

RAD Rite Aid
$14.22 /

+0.59 (+4.33%)

QRVO Qorvo
$169.45 /

+0.87 (+0.52%)

PYPL PayPal
$258.00 /

-13.63 (-5.02%)

PINS Pinterest
$62.68 /

+7.085 (+12.74%)

NXTP NextPlay Technologies
$2.46 /

-0.075 (-2.96%)

NVAX Novavax
$136.84 /

-23.6 (-14.71%)

NFLX Netflix
$625.15 /

-13.96 (-2.18%)

MU Micron
$68.27 /

+0.69 (+1.02%)

HCSG Healthcare Services
$20.01 /

-3.26 (-14.01%)

FSLR First Solar
$103.24 /

-4.97 (-4.59%)

FB Facebook
$340.85 /

+0.8 (+0.24%)

F Ford
$16.05 /

+0.625 (+4.05%)

EAT Brinker
$44.24 /

-4.68 (-9.57%)

DD DuPont
$73.24 /

+0.99 (+1.37%)

CP Canadian Pacific
$74.70 /

+1.205 (+1.64%)

CNI Canadian National
$130.51 /

+6.16 (+4.95%)

CC Chemours
$30.62 /

+0.11 (+0.36%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

ATIP ATI Physical Therapy
$2.86 /

-0.79 (-21.64%)

ANTM Anthem
$423.88 /

+30.33 (+7.71%)

ABT Abbott
$123.32 /

+3.94 (+3.30%)

NFLX Netflix
$625.15 /

-13.96 (-2.18%)

09:53 Today
Fly Intel: Top five analyst downgrades
08:37 Today Cowen
Netflix price target raised to $750 from $650 at Cowen
08:22 Today Wedbush
Netflix stagnating ARPU, rising costs overshadow subscriber growth, says Wedbush
08:12 Today Oppenheimer
Netflix price target raised to $750 from $620 at Oppenheimer
NVAX Novavax
$136.84 /

-23.6 (-14.71%)

14:03 Today Cantor Fitzgerald
Novavax submissions will 'dissipate the current debate,' says Cantor Fitzgerald
09/08/21 Cantor Fitzgerald
Novavax combo vaccine could have 'differentiating' value, says Cantor Fitzgerald
08/30/21 B. Riley
Novavax is leader in making Covid-flu combination candidate, says B. Riley
08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
VZ Verizon
$53.61 /

+1.25 (+2.39%)

10/19/21 Deutsche Bank
Verizon resumed with a Hold at Deutsche Bank
10/13/21 Morgan Stanley
Morgan Stanley says Comcast dropping network a modest near-term negative for MSG
09/20/21 Loop Capital
Verizon initiated with a Hold, $57 target at Loop Capital
09/20/21 Loop Capital
Verizon initiated with a Hold at Loop Capital
MU Micron
$68.27 /

+0.69 (+1.02%)

10/19/21 Mizuho
Micron downgraded to Neutral from Buy at Mizuho
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/14/21 Goldman Sachs
Micron price target lowered to $88 from $104 at Goldman Sachs
UAL United Airlines
$45.94 /

-0.28 (-0.61%)

08/11/21 Redburn
United Airlines initiated with a Sell at Redburn
07/22/21 MKM Partners
United Airlines price target lowered to $61 from $65 at MKM Partners
07/22/21 Susquehanna
United Airlines price target lowered to $51 from $56 at Susquehanna
07/13/21
Fly Intel: Top five analyst downgrades
F Ford
$16.05 /

+0.625 (+4.05%)

04:54 Today Credit Suisse
Ford upgraded to Outperform from Neutral at Credit Suisse
10/04/21 RBC Capital
Lordstown Motors price target raised to $5 from $1 at RBC Capital
09/28/21 Morgan Stanley
Morgan Stanley says Ford 'late to party' on BEVs, but 'turning music up loud'
09/26/21 Goldman Sachs
Lordstown Motors downgraded to Sell from Neutral at Goldman Sachs
QRVO Qorvo
$169.45 /

+0.87 (+0.52%)

10/19/21 Mizuho
Qorvo downgraded to Neutral from Buy at Mizuho
10/13/21 BofA
Cirrus, Skyworks among chip vendors with highest iPhone cut exposure, says BofA
08/05/21
Fly Intel: Top five analyst initiations
08/05/21 BMO Capital
Qorvo price target raised to $200 from $190 at BMO Capital
WDC Western Digital
$56.41 /

+0.77 (+1.38%)

10/19/21 Mizuho
Western Digital downgraded to Neutral from Buy at Mizuho
10/15/21
Fly Intel: Top five analyst downgrades
10/14/21 Goldman Sachs
Western Digital downgraded to Neutral from Buy at Goldman Sachs
10/12/21 Lynx
Lynx still bearish on Micron, would not be stepping in on long side
FSLR First Solar
$103.24 /

-4.97 (-4.59%)

08:57 Today Barclays
First Solar price target raised to $108 from $90 at Barclays
06:40 Today Guggenheim
Guggenheim downgrades First Solar to Neutral on rising estimate risk
05:34 Today Guggenheim
First Solar downgraded to Neutral from Buy at Guggenheim
09/21/21 Morgan Stanley
First Solar shares pricing in too much 'policy optimism,' says Morgan Stanley
SYF Synchrony
$51.95 /

-0.41 (-0.78%)

08:01 Today BMO Capital
Synchrony price target raised to $55 from $51 at BMO Capital
06:49 Today Deutsche Bank
Synchrony price target raised to $65 from $58 at Deutsche Bank
06:23 Today Citi
Synchrony price target raised to $56 from $51 at Citi
PYPL PayPal
$258.00 /

-13.63 (-5.02%)

15:09 Today Bernstein
PayPayl, Pinterest 'is a match NOT made in heaven,' says Bernstein
15:09 Today Keefe Bruyette
Pinterest purchase 'can make sense' for PayPal, says Keefe Bruyette
15:03 Today Cowen
Potential Pinterest deal dovetails with PayPal's Super App strategy, says Cowen
14:21 Today Baird
PayPal deal for Pinterest could help accelerate super app ambitions, says Baird
PINS Pinterest
$62.68 /

+7.085 (+12.74%)

FB Facebook
$340.85 /

+0.8 (+0.24%)

10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/18/21 Credit Suisse
Facebook algorithm, service outages grab investor attention, says Credit Suisse
10/15/21 Evercore ISI
Facebook added to 'Tactical Underperform List' at Evercore ISI
10/13/21 Tigress Financial
Facebook price target raised to $466 from $430 at Tigress Financial
XOM Exxon Mobil
$63.86 /

+0.36 (+0.57%)

10/11/21 Exane BNP Paribas
Exxon Mobil downgraded to Underperform from Neutral at Exane BNP Paribas
10/07/21 Truist
Exxon Mobil price target raised to $66 from $64 at Truist
08/03/21 DZ Bank
Exxon Mobil downgraded to Hold from Buy at DZ Bank
07/23/21 Piper Sandler
Exxon Mobil price target raised to $69 from $63 at Piper Sandler
DD DuPont
$73.24 /

+0.99 (+1.37%)

10/12/21 Mizuho
DuPont initiated with a Buy at Mizuho
10/04/21
Fly Intel: Top five analyst upgrades
10/04/21 JPMorgan
JPMorgan's Tusa downgrades 3M on lack of progress, prefers DuPont
10/04/21 JPMorgan
DuPont upgraded with share weakness 'overdriven' at JPMorgan
CC Chemours
$30.62 /

+0.11 (+0.36%)

08/05/21 BofA
Venator Materials downgraded to Neutral from Buy at BofA
08/03/21 RBC Capital
Chemours price target raised to $40 from $35 at RBC Capital
06/30/21 BMO Capital
Chemours price target raised to $48 from $42 at BMO Capital
06/09/21 Wolfe Research
Chemours initiated with an Outperform at Wolfe Research
NXTP NextPlay Technologies
$2.46 /

-0.075 (-2.96%)

08/20/21 H.C. Wainwright
NextPlay Technologies initiated with a Buy at H.C. Wainwright
RDUS Radius Health
$18.02 /

+2.555 (+16.52%)

13:59 Today Stifel
Success of Radius' elacestrant lowers risk for Arvinas' ARV-471, says Stifel
13:46 Today Stifel
Stifel ups Radius Health target to $22 following EMERALD Phase 3 trial data
11:18 Today Goldman Sachs
Radius Health price target raised to $33 from $31 at Goldman Sachs
08/06/21 H.C. Wainwright
Radius Health price target lowered to $19 from $25 at H.C. Wainwright
RAD Rite Aid
$14.22 /

+0.59 (+4.33%)

06:46 Today Deutsche Bank
Rite Aid price target raised to $15 from $13 at Deutsche Bank
06/25/21
Fly Intel: Top five analyst downgrades
06/25/21 JPMorgan
Rite Aid downgraded to Underweight from Neutral at JPMorgan
06/25/21 Deutsche Bank
Rite Aid price target lowered to $13 from $18 at Deutsche Bank
CNI Canadian National
$130.51 /

+6.16 (+4.95%)

11:03 Today National Bank
Canadian National price target raised to C$153 from C$151 at National Bank
10:47 Today BMO Capital
Canadian National price target raised to C$160 from C$155 at BMO Capital
10:34 Today Scotiabank
Canadian National price target raised to C$166 from C$160 at Scotiabank
08:27 Today BMO Capital
Canadian National price target raised to C$160 from C$155 at BMO Capital
ATIP ATI Physical Therapy
$2.86 /

-0.79 (-21.64%)

09:46 Today CJS Securities
ATI Physical Therapy downgraded to Market Perform at CJS Securities
07/27/21 Barrington
ATI Physical Therapy downgraded to Market Perform from Outperform at Barrington
07/27/21 Jefferies
Jefferies cuts ATI Physical Therapy to Hold after 'thesis changing' report
07/27/21 Citi
ATI Physical Therapy downgraded to Neutral from Buy at Citi
HCSG Healthcare Services
$20.01 /

-3.26 (-14.01%)

10:32 Today William Blair
Healthcare Services cut to Market Perform after earnings miss at William Blair
10:27 Today William Blair
Healthcare Services downgraded to Market Perform from Outperform at William Blair
06/22/21 Stifel
Healthcare Services resumed with a Hold at Stifel
02/11/21 RBC Capital
Healthcare Services price target raised to $30 from $24 at RBC Capital
BIIB Biogen
$266.28 /

-1.53 (-0.57%)

14:30 Today Piper Sandler
Biogen price target lowered to $390 from $460 at Piper Sandler
08:08 Today Piper Sandler
Biogen's Aduhelm launch 'even worse than feared,' says Piper Sandler
10/17/21 Piper Sandler
Piper Sandler remains bullish on Biogen despite mixed VALOR study update
10/15/21 Cantor Fitzgerald
Biogen price target lowered to $327 from $427 at Cantor Fitzgerald
EAT Brinker
$44.24 /

-4.68 (-9.57%)

10/19/21 Stephens
Brinker margin miss even larger than expected, says Stephens
10/18/21 KeyBanc
Brinker price target lowered to $58 from $63 at KeyBanc
10/14/21 Barclays
Brinker price target lowered to $55 from $60 at Barclays
09/28/21 OTR Global
Brinker view downgraded to Mixed from Positive at OTR Global
ABT Abbott
$123.32 /

+3.94 (+3.30%)

10/14/21 Redburn
Abbott initiated with a Neutral at Redburn
10/04/21 Cowen
Abbott Q3 results not likely to contain sales warning, says at Cowen
10/01/21 Citi
Abbott price target raised to $140 from $135 at Citi
09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
CP Canadian Pacific
$74.70 /

+1.205 (+1.64%)

10/07/21 Scotiabank
Canadian Pacific price target lowered to C$105 from C$110 at Scotiabank
09/17/21 Scotiabank
Canadian Pacific price target raised to C$110 from C$108 at Scotiabank
09/16/21 National Bank
Canadian Pacific price target lowered to C$97 from C$98 at National Bank
09/15/21 Wolfe Research
Kansas City Southern downgraded to Peer Perform from Outperform at Wolfe Research
ANTM Anthem
$423.88 /

+30.33 (+7.71%)

09/27/21 SVB Leerink
Anthem initiated with a Market Perform at SVB Leerink
09/27/21 SVB Leerink
Anthem initiated with a Market Perform at SVB Leerink
09/09/21 Cowen
Anthem can gain profitable market share, says Cowen
09/09/21 Cowen
Anthem initiated with an Outperform at Cowen
XOM Exxon Mobil
$63.86 /

+0.36 (+0.57%)

WDC Western Digital
$56.41 /

+0.77 (+1.38%)

VZ Verizon
$53.61 /

+1.25 (+2.39%)

UAL United Airlines
$45.94 /

-0.28 (-0.61%)

SYF Synchrony
$51.95 /

-0.41 (-0.78%)

RDUS Radius Health
$18.02 /

+2.555 (+16.52%)

RAD Rite Aid
$14.22 /

+0.59 (+4.33%)

QRVO Qorvo
$169.45 /

+0.87 (+0.52%)

PYPL PayPal
$258.00 /

-13.63 (-5.02%)

PINS Pinterest
$62.68 /

+7.085 (+12.74%)

NVAX Novavax
$136.84 /

-23.6 (-14.71%)

NFLX Netflix
$625.15 /

-13.96 (-2.18%)

MU Micron
$68.27 /

+0.69 (+1.02%)

HCSG Healthcare Services
$20.01 /

-3.26 (-14.01%)

FSLR First Solar
$103.24 /

-4.97 (-4.59%)

FB Facebook
$340.85 /

+0.8 (+0.24%)

F Ford
$16.05 /

+0.625 (+4.05%)

EAT Brinker
$44.24 /

-4.68 (-9.57%)

DD DuPont
$73.24 /

+0.99 (+1.37%)

CP Canadian Pacific
$74.70 /

+1.205 (+1.64%)

CNI Canadian National
$130.51 /

+6.16 (+4.95%)

CC Chemours
$30.62 /

+0.11 (+0.36%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

ATIP ATI Physical Therapy
$2.86 /

-0.79 (-21.64%)

ANTM Anthem
$423.88 /

+30.33 (+7.71%)

ABT Abbott
$123.32 /

+3.94 (+3.30%)

  • 15
    Dec
XOM Exxon Mobil
$63.86 /

+0.36 (+0.57%)

WDC Western Digital
$56.41 /

+0.77 (+1.38%)

VZ Verizon
$53.61 /

+1.25 (+2.39%)

UAL United Airlines
$45.94 /

-0.28 (-0.61%)

SYF Synchrony
$51.95 /

-0.41 (-0.78%)

RAD Rite Aid
$14.22 /

+0.59 (+4.33%)

PYPL PayPal
$258.00 /

-13.63 (-5.02%)

NXTP NextPlay Technologies
$2.46 /

-0.075 (-2.96%)

NVAX Novavax
$136.84 /

-23.6 (-14.71%)

NFLX Netflix
$625.15 /

-13.96 (-2.18%)

MU Micron
$68.27 /

+0.69 (+1.02%)

FSLR First Solar
$103.24 /

-4.97 (-4.59%)

FB Facebook
$340.85 /

+0.8 (+0.24%)

F Ford
$16.05 /

+0.625 (+4.05%)

EAT Brinker
$44.24 /

-4.68 (-9.57%)

DD DuPont
$73.24 /

+0.99 (+1.37%)

CP Canadian Pacific
$74.70 /

+1.205 (+1.64%)

CNI Canadian National
$130.51 /

+6.16 (+4.95%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

ANTM Anthem
$423.88 /

+30.33 (+7.71%)

ABT Abbott
$123.32 /

+3.94 (+3.30%)

XOM Exxon Mobil
$63.86 /

+0.36 (+0.57%)

WDC Western Digital
$56.41 /

+0.77 (+1.38%)

VZ Verizon
$53.61 /

+1.25 (+2.39%)

UAL United Airlines
$45.94 /

-0.28 (-0.61%)

SYF Synchrony
$51.95 /

-0.41 (-0.78%)

RAD Rite Aid
$14.22 /

+0.59 (+4.33%)

QRVO Qorvo
$169.45 /

+0.87 (+0.52%)

PYPL PayPal
$258.00 /

-13.63 (-5.02%)

NXTP NextPlay Technologies
$2.46 /

-0.075 (-2.96%)

NVAX Novavax
$136.84 /

-23.6 (-14.71%)

NFLX Netflix
$625.15 /

-13.96 (-2.18%)

MU Micron
$68.27 /

+0.69 (+1.02%)

FSLR First Solar
$103.24 /

-4.97 (-4.59%)

FB Facebook
$340.85 /

+0.8 (+0.24%)

F Ford
$16.05 /

+0.625 (+4.05%)

DD DuPont
$73.24 /

+0.99 (+1.37%)

CP Canadian Pacific
$74.70 /

+1.205 (+1.64%)

CNI Canadian National
$130.51 /

+6.16 (+4.95%)

CC Chemours
$30.62 /

+0.11 (+0.36%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

ATIP ATI Physical Therapy
$2.86 /

-0.79 (-21.64%)

ANTM Anthem
$423.88 /

+30.33 (+7.71%)

ABT Abbott
$123.32 /

+3.94 (+3.30%)

XOM Exxon Mobil
$63.86 /

+0.36 (+0.57%)

WDC Western Digital
$56.41 /

+0.77 (+1.38%)

VZ Verizon
$53.61 /

+1.25 (+2.39%)

UAL United Airlines
$45.94 /

-0.28 (-0.61%)

SYF Synchrony
$51.95 /

-0.41 (-0.78%)

RAD Rite Aid
$14.22 /

+0.59 (+4.33%)

PYPL PayPal
$258.00 /

-13.63 (-5.02%)

PINS Pinterest
$62.68 /

+7.085 (+12.74%)

NVAX Novavax
$136.84 /

-23.6 (-14.71%)

NFLX Netflix
$625.15 /

-13.96 (-2.18%)

MU Micron
$68.27 /

+0.69 (+1.02%)

FSLR First Solar
$103.24 /

-4.97 (-4.59%)

FB Facebook
$340.85 /

+0.8 (+0.24%)

F Ford
$16.05 /

+0.625 (+4.05%)

EAT Brinker
$44.24 /

-4.68 (-9.57%)

DD DuPont
$73.24 /

+0.99 (+1.37%)

CP Canadian Pacific
$74.70 /

+1.205 (+1.64%)

CNI Canadian National
$130.51 /

+6.16 (+4.95%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

ATIP ATI Physical Therapy
$2.86 /

-0.79 (-21.64%)

ANTM Anthem
$423.88 /

+30.33 (+7.71%)

ABT Abbott
$123.32 /

+3.94 (+3.30%)

Hot Stocks
Fusion Pharma's targeted Alpha therapies demonstrate therapeutic efficacy » 16:26
10/20/21
10/20
16:26
10/20/21
16:26
FUSN

Fusion Pharmaceuticals

$7.59 /

+0.09 (+1.20%)

Fusion Pharmaceuticals…

Fusion Pharmaceuticals announced the presentation of preclinical data that provide further support of its FPI-1966 and FPI-2059 targeted alpha therapies at the 34th Annual European Association of Nuclear Medicine Congress. These data reinforce the clinical dosing regimen of FPI-1966 and highlight the potential of FPI-2059 as an actinium-225 labelled precision medicine targeting NTSR1. Outcomes demonstrated that FPI-1966 when administered with vofatamab results in high tumor delivery and low off-target uptake. Further, the data showed therapeutic efficacy of FPI-1966 at both single and multiple doses in a preclinical bladder cancer xenograft model. Data from preclinical studies of FPI-2059, a TAT designed to target and deliver actinium-225 to cancer cells expressing neurotensin receptor 1, were presented in an oral presentation.Results demonstrate superior efficacy with FPI-2059 in a mouse xenograft model of colorectal cancer.

ShowHide Related Items >><<
FUSN Fusion Pharmaceuticals
$7.59 /

+0.09 (+1.20%)

FUSN Fusion Pharmaceuticals
$7.59 /

+0.09 (+1.20%)

10/19/21 Morgan Stanley
Fusion Pharmaceuticals assumed with an Overweight at Morgan Stanley
08/26/21 B. Riley
B. Riley starts Fusion Pharmaceuticals with Buy, sees over 100% upside
08/26/21 B. Riley
Fusion Pharmaceuticals initiated with a Buy at B. Riley
FUSN Fusion Pharmaceuticals
$7.59 /

+0.09 (+1.20%)

FUSN Fusion Pharmaceuticals
$7.59 /

+0.09 (+1.20%)

Syndicate
ADMA Biologics files to sell common stock, no amount given » 16:01
10/20/21
10/20
16:01
10/20/21
16:01
ADMA

ADMA Biologics

$1.11 /

-0.005 (-0.45%)

Raymond James &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADMA ADMA Biologics
$1.11 /

-0.005 (-0.45%)

ADMA ADMA Biologics
$1.11 /

-0.005 (-0.45%)

07/06/21 H.C. Wainwright
ADMA Biologics price target lowered to $7 from $10 at H.C. Wainwright
ADMA ADMA Biologics
$1.11 /

-0.005 (-0.45%)

ADMA ADMA Biologics
$1.11 /

-0.005 (-0.45%)

ADMA ADMA Biologics
$1.11 /

-0.005 (-0.45%)

On The Fly
Novavax plunges despite company's 'confidence' in COVID vaccine production » 14:45
10/20/21
10/20
14:45
10/20/21
14:45
NVAX

Novavax

$134.80 /

-25.64 (-15.98%)

Shares of Novavax (NVAX)…

ShowHide Related Items >><<
NVAX Novavax
$134.80 /

-25.64 (-15.98%)

NVAX Novavax
$134.80 /

-25.64 (-15.98%)

14:03 Today Cantor Fitzgerald
Novavax submissions will 'dissipate the current debate,' says Cantor Fitzgerald
09/08/21 Cantor Fitzgerald
Novavax combo vaccine could have 'differentiating' value, says Cantor Fitzgerald
08/30/21 B. Riley
Novavax is leader in making Covid-flu combination candidate, says B. Riley
08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
NVAX Novavax
$134.80 /

-25.64 (-15.98%)

NVAX Novavax
$134.80 /

-25.64 (-15.98%)

NVAX Novavax
$134.80 /

-25.64 (-15.98%)

NVAX Novavax
$134.80 /

-25.64 (-15.98%)

Recommendations
Novavax submissions will 'dissipate the current debate,' says Cantor Fitzgerald » 14:03
10/20/21
10/20
14:03
10/20/21
14:03
NVAX

Novavax

$133.82 /

-26.62 (-16.59%)

After speaking with…

After speaking with management, Cantor Fitzgerald analyst Charles Duncan says Novavax is past commercial scale-up activities and finalizing the regulatory submissions for its Covid vaccine. The filing submissions "will dissipate the current debate of vaccine quality and the release assays," Duncan tells investors in a research note. He points out that Novavax is currently testing assays against product, prior to the submission of the final chemistry, manufacturing and control package. Further, Novavax is maintaining its guidance of 150M doses of monthly run rate capacity by the end of 2021, says Duncan. The analyst keeps an Overweight rating on the shares with a $272 price target.

ShowHide Related Items >><<
NVAX Novavax
$133.82 /

-26.62 (-16.59%)

NVAX Novavax
$133.82 /

-26.62 (-16.59%)

09/08/21 Cantor Fitzgerald
Novavax combo vaccine could have 'differentiating' value, says Cantor Fitzgerald
08/30/21 B. Riley
Novavax is leader in making Covid-flu combination candidate, says B. Riley
08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
NVAX Novavax
$133.82 /

-26.62 (-16.59%)

NVAX Novavax
$133.82 /

-26.62 (-16.59%)

NVAX Novavax
$133.82 /

-26.62 (-16.59%)

NVAX Novavax
$133.82 /

-26.62 (-16.59%)

Recommendations
Success of Radius' elacestrant lowers risk for Arvinas' ARV-471, says Stifel » 13:59
10/20/21
10/20
13:59
10/20/21
13:59
ARVN

Arvinas

$85.95 /

+3.33 (+4.03%)

, RDUS

Radius Health

$18.57 /

+3.105 (+20.08%)

After Radius Health…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDUS Radius Health
$18.57 /

+3.105 (+20.08%)

ARVN Arvinas
$85.95 /

+3.33 (+4.03%)

ARVN Arvinas
$85.95 /

+3.33 (+4.03%)

10/14/21 SVB Leerink
Arvinas initiated with an Outperform at SVB Leerink
09/29/21 Stifel
Arvinas initiated with a Buy at Stifel
09/09/21 BofA
Arvinas initiated with a Buy at BofA
09/09/21 BofA
Arvinas initiated with a Buy at BofA
RDUS Radius Health
$18.57 /

+3.105 (+20.08%)

13:46 Today Stifel
Stifel ups Radius Health target to $22 following EMERALD Phase 3 trial data
11:18 Today Goldman Sachs
Radius Health price target raised to $33 from $31 at Goldman Sachs
08/06/21 H.C. Wainwright
Radius Health price target lowered to $19 from $25 at H.C. Wainwright
03/22/21 Goldman Sachs
Radius Health assumed with a Buy at Goldman Sachs
RDUS Radius Health
$18.57 /

+3.105 (+20.08%)

ARVN Arvinas
$85.95 /

+3.33 (+4.03%)

  • 16
    Dec
RDUS Radius Health
$18.57 /

+3.105 (+20.08%)

RDUS Radius Health
$18.57 /

+3.105 (+20.08%)

Hot Stocks
Sorrento's Covistix receives CE Mark, registration of device » 13:42
10/20/21
10/20
13:42
10/20/21
13:42
SRNE

Sorrento Therapeutics

$6.38 /

-0.35 (-5.20%)

Sorrento Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$6.38 /

-0.35 (-5.20%)

SRNE Sorrento Therapeutics
$6.38 /

-0.35 (-5.20%)

08/09/21 H.C. Wainwright
Sorrento Therapeutics price target lowered to $26 from $30 at H.C. Wainwright
03/26/21 B. Riley
Sorrento data make case for expedited EUA filing path, says B. Riley Securities
01/29/21 B. Riley
Sorrento Therapeutics initiated with a Buy at B. Riley Securities
01/21/21 Alliance Global Partners
Sorrento Therapeutics initiated with a Buy at Alliance Global Partners
SRNE Sorrento Therapeutics
$6.38 /

-0.35 (-5.20%)

SRNE Sorrento Therapeutics
$6.38 /

-0.35 (-5.20%)

SRNE Sorrento Therapeutics
$6.38 /

-0.35 (-5.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.